Saul R Korey Department of Neurology, Albert Einstein College of Medicine, 1410 Pelham Parkway South, Kennedy Center, Room 306, Bronx, NY 10461, USA.
Biomark Med. 2011 Oct;5(5):615-28. doi: 10.2217/bmm.11.71.
Epilepsy and seizures are very common in the early years of life and are often associated with significant morbidity and mortality. Identification of biomarkers for the early detection of epileptogenicity, epileptogenesis, comorbidities, disease progression and treatment implementation will be very important in implementing more effective therapies. This article summarizes the current needs in the search for new early life epilepsy-related biomarkers and discusses the candidate biomarkers that are under investigation, as well as the challenges associated with the identification and validation of these biomarkers.
癫痫和发作在生命早期非常常见,通常与显著的发病率和死亡率相关。识别生物标志物对于早期发现致痫性、癫痫发生、合并症、疾病进展和治疗实施将非常重要,有助于实施更有效的治疗方法。本文总结了目前在寻找新的与生命早期癫痫相关的生物标志物方面的需求,并讨论了正在研究的候选生物标志物,以及鉴定和验证这些生物标志物所面临的挑战。